Login
Register
Complete Your Profile
Change Password
Request a Password Reset
Download Documents
Download Documents
Get Help to Participate in This Tender
Change Password
For better security, update the account password.
The UNIVERSITY CLINICAL HOSPITAL IN POZNAŃ has issued a Tender notice for the procurement of a Delivery of the Medicinal Product Mirvetuximab Soravtansine as Part of the B.50 Drug Program Treatment of Patients with Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer - 1 Product Package in the Poland. This Tender notice was published on 22 Oct 2025 and is scheduled to close on 30 Oct 2025, with an estimated Tender value of Refer Document. Interested bidders can access detailed Tender information, eligibility criteria, and complete bidding documents by referencing TOT Ref No. 128634483, while the tender notice number is 2025/BZP 00486411/01 and Registering on the platform.
Procurement Summary
Country: Poland
Summary: Delivery of the Medicinal Product Mirvetuximab Soravtansine as Part of the B.50 Drug Program Treatment of Patients with Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer - 1 Product Package
Deadline: 30 Oct 2025
Posting Date: 22 Oct 2025
Other Information
Notice Type: Tender
TOT Ref.No.: 128634483
Document Ref. No.: 2025/BZP 00486411/01
Competition: ICB
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: Refer Document
CPV Classification
33600000 - Pharmaceutical productsPurchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_details
Login to see detailsTender Details
SECTION II - BASIC INFORMATION 2.1.) The announcement concerns: Public procurement 2.2.) The announcement concerns social services and other specific services: No 2.3.) Name of the order or framework agreement: Delivery of the medicinal product Mirvetuximab soravtansine in as part of the B.50 Drug Program TREATMENT OF PATIENTS WITH OVARIAN CANCER, Fallopian tube cancer or peritoneal cancer - 1 assortment package 2.4.) Procedure ID: ocds-148610-706f0e7a-a61d-4c68-9b09-798b226ca968 2.5.) Announcement number: 2025/BZP 00486411 2.6.) Version announcements: 01 2.7.) Date of announcement: 2025-10-21 2.8.) The order or framework agreement was included in the procedure plan: No 2.11.) Only contractors referred to in Art. 94 of the Act: No 2.14.) Do the order either the framework agreement concerns a project or program co-financed by the European Union: No 2.16.) Procedure for awarding the contract along with the legal basis The order is awarded in the basic mode on the basis of: Art. 275 point 1 of the Act
Category: Deliveries Date: 2025-10-21 2025-10-30 add to watchlist City: Poznań Description: Delivery of the medicinal product Mirvetuximab soravtansine as part of the B.50 Drug Program TREATMENT OF PATIENTS WITH OVARIAN CANCER, Fallopian tube cancer or peritoneal cancer - 1 package assortment
Documents
Similar Tenders
Poland
149766383
02 Oct 2026
Refer Document
Poland
149766368
30 Sep 2026
Refer Document
Poland
149766367
05 Oct 2026
Refer Document
Procurement Documents for Poland
Access a comprehensive library of standard procurement documents specific to Poland. Here, you'll find all the essential forms, guidelines, and templates required for tender applications and submissions in Poland
Want To Bid in This Tender?
Get Local Agent Support in Poland and 60 More Countries.
View Tenders By
Sign in with Google